Glucocorticoids-Induced Hypertension: The Prevalence and Risk Factors


Nahid Kianmehr 1 , Anousheh Haghighi 2 , Mohsen arabi 2 , Mani Mofidi 1 , Ali Bidari 2 , Maryam Ebadifardazar 2 , Hossein Shayan Moghadam 3 , *

1 Department of Internal Medicine,Iran University of Medical Sciences,Tehran,Iran

2 Department of Internal Medicine,Iran University of Medical Sciences,Tehran,Iran.

3 Department of Internal Medicine,Kerman University of Medical Sciences,Kerman,Iran.

How to Cite: Kianmehr N , Haghighi A, arabi M, Mofidi M , Bidari A , et al. Glucocorticoids-Induced Hypertension: The Prevalence and Risk Factors, Hormozgan Med J. 2017 ; 21(2):e87278. doi: 10.29252/hmj.21.2.105.


Hormozgan Medical Journal: 21 (2); e87278
Published Online: September 05, 2017
Article Type: Research Article
Received: May 16, 2017
Accepted: September 05, 2017


Introduction: Despite benefits in the treatment of most autoimmune and inflammatory
diseases, glucocorticoids (GCs) have proved side effects including hypertension, diabetes,
osteoporosis and lipid disorders. Determining the risk factors for hypertension can facilitate
the identification of high-risk individuals and lead to effective control of the side effects. The
present study aimed to determine the risk factors for hypertension in individuals receiving
high-dose GCs.
Methods: This prospective study recruited 140 adults (age>18 years) requiring
prednisolone or equivalent more than 30mg daily for at least three months. The
participants’ blood pressure was monitored every month and correlations between the
incidence of hypertension and variables such as serum calcium levels, weight, underlying
diseases, body mass index (BMI), and folic acid use were investigated by repeated
measure analysis.
Results: While none of the subjects were hypertensive at baseline, 55 patients (39.28%)
developed hypertension during the course of the study. Baseline weight and BMI,
cumulative GC dose, family history of hypertension, and age were significantly higher in
hypertensive patients.
Conclusion: High BMI, male gender, elderly, family history of hypertension may have
impact on development of hypertension in patients taking GCs.



  • 1.

    Refrences are included in the PDF.

  • © 2017, Hormozgan Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.